The approval of vedolizumab for the management of inflammatory bowel diseases in brazil: the beginning of a new biological era

Kotze, Paulo Gustavo; Damião, Aderson Omar Mourão Cintra; Moraes, Antonio Carlos

Kotze, Paulo Gustavo; Damião, Aderson Omar Mourão Cintra; Moraes, Antonio Carlos.

Kotze, Paulo Gustavo; PUCPR. Hospital Universitário Cajuru. Serviço de Coloproctologia. Curitiba. BR
Damião, Aderson Omar Mourão Cintra; PUCPR. Hospital Universitário Cajuru. Serviço de Coloproctologia. Curitiba. BR
Moraes, Antonio Carlos; PUCPR. Hospital Universitário Cajuru. Serviço de Coloproctologia. Curitiba. BR

Arq. gastroenterol ; 53(1): 3-4, Jan.-Mar. 2016.

Article in English | LILACS | ID: lil-777111

Subject(s)

Humans; Colitis, Ulcerative/drug therapy; Crohn Disease/drug therapy; Antibodies, Monoclonal, Humanized/therapeutic use; Brazil; Randomized Controlled Trials as Topic; Drug Approval

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Colitis, Ulcerative / Crohn Disease / Antibodies, Monoclonal, Humanized Type of study: Controlled clinical trial Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Arq. gastroenterol Journal subject: Gastroenterology Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: PUCPR/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google